The Future of Healthcare: The Potential and Challenges of Virtual Wards

By Staff Writer

November 14, 2023

Embracing the Potential and Challenges of Virtual Wards

The National Institute for Health and Care Excellence (NICE) has recently recommended the exploration of virtual wards in healthcare. Virtual care is not a new concept. Recent health crises, like the COVID-19 pandemic, have propelled it into the spotlight. Virtual care, including telehealth and remote patient monitoring, has shown great promise in improving access to care, especially for those in remote or underserved areas. For example, early warning scores, such as NEWS2 and CRB65, are transforming the way we assess patients with suspected Acute Respiratory Infections (ARIs). These scores offer a promising avenue for clinical decision-making, especially in remote settings like call centres or primary care. They can be instrumental in determining care pathways, such as whether to send patients home, to ARI virtual wards, or to same day emergency care.

 

The Future of Remote Contact with NHS Services

Remote contact with National Health Service (NHS) services is gaining momentum. The guideline committee has made recommendations based on their expertise and experience, despite the fact that there is a lack of evidence on the use of remote assessments for those who have a suspicion that they have ARI. They are of the opinion that remote evaluations can be a beneficial tool for identifying persons who do not have major illnesses. However, they believe that an in-person assessment is essential for people who do have severe diseases.

The committee has also emphasised the significance of accessibility. Recognising that not everyone has equal access to or the capacity to use digital technology. However, they have emphasised the value of accessibility nonetheless. As a result, they have suggested that alternatives should be provided whenever they are required, and that the NHS has a responsibility to give reasonable adjustments to patients who have requirements in this regard.

As a result of the committee’s recommendations, antimicrobial stewardship is expected to be improved. This will lead to the beginning of a new era in healthcare. This will be accomplished by reducing the amount of antimicrobials that are prescribed without an in-person assessment.

Reference url

Recent Posts

Mavyret acute hepatitis C
         

Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implications

🌟 Did you know that the FDA has just approved the first-ever treatment specifically for acute Hepatitis C?

AbbVie’s Mavyret (glecaprevir/pibrentasvir) is now set to improve the way we think about HCV interventions, enabling earlier treatment to reduce long-term complications and improve patient outcomes. This approval not only addresses an urgent public health need but also aligns with evolving healthcare delivery models focused on cost-effective solutions.

Curious to learn more about the implications of this significant advancement in hepatitis care? Review the full article for insightful analysis on the future of HCV treatment!

#SyenzaNews #HealthcareInnovation #MarketAccess #HealthEconomics

HIV vaccine trials
    

Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies

🌍 Are we finally making strides in the fight against HIV?

Recent phase 1 vaccine trials using mRNA technology have shown promising results in activating immune responses that could lead to broadly neutralizing antibodies (bnAbs). This innovative approach not only addresses HIV’s rapid mutation but also offers critical insights for high-prevalence regions.

Dive into the full article to explore how these trials could shape the future of HIV prevention and what it means for global health!

#SyenzaNews #globalhealth #HIV #clinicaltrials

EHK clusters 2026 report
       

EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Cost Pharmaceuticals

🚀 Are you curious about how the Dutch healthcare system is adapting to high-cost pharmaceuticals?

The latest EHK clusters report for 2026 brings crucial updates to the risk-equalization model, enhancing equity among health insurers while closely managing skyrocketing costs. With innovative clustering techniques and revised reimbursement figures, these changes aim to improve access and accountability in an increasingly competitive healthcare landscape.

Dive into the full article to uncover the implications for health economics and policy!

#SyenzaNews #HealthEconomics #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.